USFDA issues warning to Shilpa Medicare for CGMP violations at Telangana plant

USFDA issues warning to Shilpa Medicare for CGMP violations at Telangana plant In a letter to company#39;#39;s Managing Director Vishnukant Chaturbhuj Bhutada, the US health regulator said its inspectors, from February 13-20 and February 24-25, 2020, found significant deviations from standard manufacturing practices at company#39;#39;s Unit-IV at Polepally village in Mahabubnagar district.

from Moneycontrol Business News https://ift.tt/3oM1grc
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...